Skip to main content
Journal cover image

Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation.

Publication ,  Journal Article
Kruser, TJ; Gondi, V; Sperduto, PW; Brown, PD; Mehta, MP
Published in: Lancet Oncol
August 2018

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Lancet Oncol

DOI

EISSN

1474-5488

Publication Date

August 2018

Volume

19

Issue

8

Start / End Page

e366

Location

England

Related Subject Headings

  • Radiosurgery
  • Oncology & Carcinogenesis
  • Nivolumab
  • Melanoma
  • Ipilimumab
  • Humans
  • Brain Neoplasms
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kruser, T. J., Gondi, V., Sperduto, P. W., Brown, P. D., & Mehta, M. P. (2018). Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation. Lancet Oncol, 19(8), e366. https://doi.org/10.1016/S1470-2045(18)30439-X
Kruser, Tim J., Vinai Gondi, Paul W. Sperduto, Paul D. Brown, and Minesh P. Mehta. “Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation.Lancet Oncol 19, no. 8 (August 2018): e366. https://doi.org/10.1016/S1470-2045(18)30439-X.
Kruser TJ, Gondi V, Sperduto PW, Brown PD, Mehta MP. Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation. Lancet Oncol. 2018 Aug;19(8):e366.
Kruser, Tim J., et al. “Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation.Lancet Oncol, vol. 19, no. 8, Aug. 2018, p. e366. Pubmed, doi:10.1016/S1470-2045(18)30439-X.
Kruser TJ, Gondi V, Sperduto PW, Brown PD, Mehta MP. Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation. Lancet Oncol. 2018 Aug;19(8):e366.
Journal cover image

Published In

Lancet Oncol

DOI

EISSN

1474-5488

Publication Date

August 2018

Volume

19

Issue

8

Start / End Page

e366

Location

England

Related Subject Headings

  • Radiosurgery
  • Oncology & Carcinogenesis
  • Nivolumab
  • Melanoma
  • Ipilimumab
  • Humans
  • Brain Neoplasms
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis